GlassScriptPhysician profile
Ryan S Orgill
NPI 1598962755
$2,842.81
in general payments reported to CMS, 2019-2025
12 companies · $296 in 2025
The $296 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,022 · 2020: $120 · 2021: $688 · 2022: $253 · 2023: $238 · 2024: $226 · 2025: $296.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $760.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $759.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $791.64 | 2019-2025 | Myday Contact Lens, Clariti Contact Lens |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $753.39 | 2019-2021 | |
| Alcon Vision LLC | $278.81 | 2021-2025 | Precision7 |
| Bausch & Lomb Americas INC. | $249.40 | 2024-2025 | Infuse, Biotrue One Day |
| Allergan, INC. | $245.25 | 2019-2021 | |
| Ivantis, INC | $125.00 | 2019 | |
| Lumenis, INC | $102.52 | 2019 | |
| Carl Zeiss Meditec USA, INC. | $83.27 | 2023 | Forum |
| Carl Zeiss Meditec, INC. | $71.12 | 2019 | |
| Abb Con-Cise Optical Group LLC | $67.65 | 2020 | |
| Carl Zeiss Meditec Ag | $38.80 | 2020 | |
| Kala Pharmaceuticals, INC. | $35.96 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Orgill listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.